Sherry L. Taylor

1.0k citations
15 papers · 813 indexed · h-index 10
Topics
Pituitary Gland Disorders and Treatments (6 papers)Head and Neck Surgical Oncology (4 papers)Peptidase Inhibition and Analysis (3 papers)

In The Last Decade

Sherry L. Taylor

15 papers receiving 795 citations

Peers

Sherry L. Taylor
Comparison fields: 5 of 73
  • Molecular Biology 473
  • Oncology 205
  • Immunology 165
  • Genetics 159
  • Cancer Research 149
Replace Dennis Pfaff with:
Dennis Pfaff Switzerland
Xiao–Tang Kong United States
Shu Uin Gan Singapore
Maree V. Hammett Australia
Ivana Manini Italy
E. Di Marco Italy
Agadha Wickremesekera New Zealand
Suojun Zhang China
Hernán Garcı́a Rivello Argentina
Sherry L. Taylor relative to Dennis Pfaff Switzerland Dennis Pfaff's profile →
Citations per field
00.5×
Dennis Pfaff · 1×
Citations per year

Countries citing papers authored by Sherry L. Taylor

Since Specialization
Citations

This map shows the geographic impact of Sherry L. Taylor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sherry L. Taylor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sherry L. Taylor more than expected).

Fields of papers citing papers by Sherry L. Taylor

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sherry L. Taylor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sherry L. Taylor. The network helps show where Sherry L. Taylor may publish in the future.

Co-authorship network of co-authors of Sherry L. Taylor

This figure shows the co-authorship network connecting the top 25 collaborators of Sherry L. Taylor. A scholar is included among the top collaborators of Sherry L. Taylor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sherry L. Taylor. Sherry L. Taylor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
#WorkIndexed citations
1 58
2 59
3 124
4 135
5 1
6 218
7 8
8 32
9 39
10 6
11 55
12 36
13 34
14 2
15 6

About Sherry L. Taylor

Sherry L. Taylor is a scholar working on Endocrinology, Diabetes and Metabolism, Oncology and Immunology and Allergy, having authored 15 papers that have together received 813 indexed citations. Recurring topics across this work include Pituitary Gland Disorders and Treatments (6 papers), Head and Neck Surgical Oncology (4 papers) and Peptidase Inhibition and Analysis (3 papers). The work is most often cited by research in Genetics (159 citations), Cancer Research (149 citations) and Immunology (165 citations). Sherry L. Taylor has collaborated with scholars based in United States, Australia and Thailand. Frequent co-authors include Dennis Oh, Ralph Francescone, Steve Scully, Brooke Bentley, Luis Moral, Wei Yan, Rong Shao, Michael Faibish, Charles B. Wilson and James Tyrrell. Their work appears in journals such as Journal of Biological Chemistry, Journal of Neuroscience and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026